1. Fas/CD95, Lipid Rafts, and Cancer
   Faustino Mollinedo et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
2. Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
   Leonie De Wilt et al, 2024, Cancer Drug Resistance CrossRef
3. Regulation of Death Receptor Signaling by S-Palmitoylation and Detergent-Resistant Membrane Micro Domains—Greasing the Gears of Extrinsic Cell Death Induction, Survival, and Inflammation
   Jürgen Fritsch et al, 2021, Cancers CrossRef